nicorandil has been researched along with Alveolitis, Fibrosing in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eladl, AE; Kseibati, MO; Salem, HA; Sharawy, MH; Shehatou, GSG | 1 |
| El-Kashef, DH | 1 |
2 other study(ies) available for nicorandil and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Nicorandil ameliorates bleomycin-induced pulmonary fibrosis in rats through modulating eNOS, iNOS, TXNIP and HIF-1α levels.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bronchoalveolar Lavage Fluid; Cell Cycle Proteins; Hypoxia-Inducible Factor 1, alpha Subunit; L-Lactate Dehydrogenase; Lung; Male; Nicorandil; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley | 2020 |
Nicorandil ameliorates pulmonary inflammation and fibrosis in a rat model of silicosis.
Topics: Animals; Collagen; Disease Models, Animal; Male; Nicorandil; Nitric Oxide Synthase Type II; Pneumonia; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Silicosis; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2018 |